Coskuns research contributions span the entire development arc of GLP3: Discovery and initial characterization of GLP3s triple-receptor agonist properties and pharmacological profile Preclinical studies establishing proof-of-mechanism in mouse models and in vitro receptor systems Design and medical oversight of phase 1b and phase 2 clinical trials in type 2 diabetes and obesity Investigation of GLP3s effects on gastric emptying and mechanistic studies of weight loss Contribution to over 168 peer-reviewed publications in metabolic disease research with citation impact exceeding 8,700 citations His work extends beyond GLP3 to include fundamental contributions to the development of GLP2 and advancement of incretin-based therapeutics more broadly
No manufacturers, states or Medicare plans are required to join, and access will depend on which entities opt in
Morning supplementation can improve energy levels, enhance cognitive clarity, and aid metabolic processes like glucose utilization and fat metabolism
Researchers found that the effectiveness of muscle-building supplements could be entirely dependent on vitamin D status, creating what essentially functions as a "bottleneck" in the muscle-building process
GLP-1 drugs can lead to significant weight loss and improved glycemic control, which, while generally beneficial, may stress the optic nerve in susceptible individuals
Start with the right antioxidant
)
